Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060037
Filing Date
2013-11-08
Accepted
2013-11-08 16:46:17
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v358770_10q.htm 10-Q 1154241
2 EXHIBIT 10.1 v358770_ex10-1.htm EX-10.1 85874
3 EXHIBIT 31.1 v358770_ex31-1.htm EX-31.1 23043
4 EXHIBIT 31.2 v358770_ex31-2.htm EX-31.2 23164
5 EXHIBIT 32.1 v358770_ex32-1.htm EX-32.1 12718
  Complete submission text file 0001144204-13-060037.txt   5451506

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ecyt-20130930.xml EX-101.INS 868573
7 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20130930.xsd EX-101.SCH 23913
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20130930_cal.xml EX-101.CAL 28904
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20130930_def.xml EX-101.DEF 146651
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20130930_lab.xml EX-101.LAB 210828
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20130930_pre.xml EX-101.PRE 183377
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 131205388
SIC: 2834 Pharmaceutical Preparations